Trials / Completed
CompletedNCT04893239
Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Lumen Bioscience, Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, single-site, open label, exploratory study to assess delivery of LMN-201 components via enteric capsules in the gut of individuals with ostomies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LMN-201 Anti-toxin B VHH-1 | Components of LMN-201 |
| BIOLOGICAL | LMN-201 Anti-toxin B VHH-2 | Components of LMN-201 |
| BIOLOGICAL | LMN-201 Anti-toxin B VHH-3 | Components of LMN-201 |
| BIOLOGICAL | LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3 | Components of LMN-201 |
Timeline
- Start date
- 2021-08-18
- Primary completion
- 2022-02-23
- Completion
- 2022-02-23
- First posted
- 2021-05-19
- Last updated
- 2025-03-18
- Results posted
- 2025-03-18
Locations
3 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT04893239. Inclusion in this directory is not an endorsement.